About Tantti
Tantti is a company based in Taoyuan City (Taiwan) founded in 2014 was acquired by Repligen in July 2024. Tantti operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Taoyuan City, Taiwan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tantti
Detailed funding history for Tantti
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Tantti
Tantti has secured backing from 1 investor. Prominent investors backing the company include Repligen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Products and services for biologic drug manufacturing are supplied.
|
Locked | Locked | Locked |
Investor details for Tantti
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tantti
Investment portfolio details for Tantti
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tantti
Detailed financials for Tantti
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tantti Comparisons
Peer comparison for Tantti
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tantti
Tantti operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Tantti
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tantti
Complete news archive for Tantti
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tantti
Tantti was founded in 2014.
Tantti is headquartered in Taoyuan City, Taiwan.
Tantti has developed tools for synthesis of self-assembly based ordered nanostructures. The core technology of the company synthesize uniform microspheres from 100 nm to 5000 nm and generate unified air bubbles from 60 µm to 500 µm via a microfluidic device. They can be applied in bio-scaffolds, skin substitutes, monolithic columns, bio-reactor, separation media, and sensors. The collagenbiomaterial scaffolds developed using this technology has shown potentials in areas of 3D cell culture, skin substitute, injectable scaffolds, and regenerative medicine. Additionally, the company offers contract research services.
Tantti's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Tantti has 1 investor. Key investors include Repligen.